From: Is pathology necessary to predict mortality among men with prostate-cancer?
 | HR 95% CI | p | |
---|---|---|---|
Age | 1.113 (1.102-1.123) | <0.0001 | |
Year of cohort entry | 0.952 (0.937-0.967) | <0.0001 | |
Rural | 1.28 (1.12-1.47) | 0.0003 | |
Co morbidity ADGs | Low | Ref | Â |
Intermediate | 1.3 (1.14-1.5) | <0.0001 | |
High | 1.64 (1.45-1.87) | <0.0001 | |
SES status | 1 | Ref | Â |
2 | 0.941 (0.81-1.1) | 0.43 | |
3 | 0.94 (0.8-1.1) | 0.42 | |
4 | 0.78 (0.66-0.92) | 0.004 | |
5 | 0.87 (0.75-1.0) | 0.11 |